Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
Clinical trial NCT00918450 · WITHDRAWN
Trial details
- NCT number
- NCT00918450
- Sponsor
- Abbott
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.